Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026 (Letter of Intent)
Funding Amounts: $750,000 total ($250,000/year for 3 years; up to 10% indirect costs included)
Summary: Supports early-to-mid-career investigators pursuing innovative, high-risk research on neurodegenerative diseases through interdisciplinary collaboration.
Key Information: Forecasted grant—dates and details subject to change; check program page for updates.